Synapse

← Cancer Drug Resistance

Papers in Cancer Drug Resistance

Page 10 · newest first

  1. New insights into acquired endocrine resistance of breast cancerCancer Drug Resistance · 2019
  2. Resistance to ERK1/2 pathway inhibitors; sweet spots, fitness deficits and drug addictionCancer Drug Resistance · 2019
  3. Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancerCancer Drug Resistance · 2019
  4. Enhanced Kat3A/Catenin transcription: a common mechanism of therapeutic resistanceCancer Drug Resistance · 2019
  5. MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapyCancer Drug Resistance · 2019
  6. Drug targets and resistance mechanisms in multiple myelomaCancer Drug Resistance · 2018
  7. Targeted therapies in cancer: where are we going?Cancer Drug Resistance · 2018
  8. How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?Cancer Drug Resistance · 2018
  9. Cancer drug resistance: a new perspectiveCancer Drug Resistance · 2018
  10. Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutationsCancer Drug Resistance · 2018
  11. Identification and targeting of CD22ΔE12 as a molecular RNAi target to overcome drug resistance in high-risk B-lineage leukemias and lymphomasCancer Drug Resistance · 2018
  12. Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancerCancer Drug Resistance · 2018
  13. Antibody drug conjugate development in gastrointestinal cancers: hopes and hurdles from clinical trialsCancer Drug Resistance · 2018
  14. Hitting a moving target: inhibition of the nuclear export receptor XPO1/CRM1 as a therapeutic approach in cancerCancer Drug Resistance · 2018
  15. Wilms’ tumor gene (WT1) is strongly expressed in high-risk subsets of pediatric acute lymphoblastic leukemiaCancer Drug Resistance · 2018
  16. Sphingolipid metabolism and drug resistance in ovarian cancerCancer Drug Resistance · 2018
  17. Epigenetics, a key player of immunotherapy resistanceCancer Drug Resistance · 2018
  18. Glutamine metabolism in cancer therapyCancer Drug Resistance · 2018
  19. What really matters - response and resistance in cancer therapyCancer Drug Resistance · 2018